{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:26:07Z","timestamp":1790504767148,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T00:00:00Z","timestamp":1554768000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/igo\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.vaccine.2019.01.015","type":"journal-article","created":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T11:35:48Z","timestamp":1548329748000},"page":"A77-A84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"S1","title":["Priorities in applied research to ensure programmatic success in the global elimination of canine rabies"],"prefix":"10.1016","volume":"37","author":[{"given":"Charles E.","family":"Rupprecht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan V.","family":"Kuzmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gowri","family":"Yale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thirumeni","family":"Nagarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois-Xavier","family":"Meslin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2019.01.015_b0005","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/S1473-3099(17)30574-1","article-title":"Comparative pathogenesis of rabies in bats and carnivores, and implications for spillover to humans","volume":"18","author":"Begeman","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2019.01.015_b0010","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2217\/fvl.15.26","article-title":"Why we can prevent, control and possibly treat \u2013 but will not eradicate rabies","volume":"10","author":"Rupprecht","year":"2015","journal-title":"Future Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2019.01.015_b0015","doi-asserted-by":"crossref","first-page":"e0003709","DOI":"10.1371\/journal.pntd.0003709","article-title":"Estimating the global burden of endemic canine rabies","volume":"9","author":"Hampson","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2019.01.015_b0020","doi-asserted-by":"crossref","first-page":"e0006271","DOI":"10.1371\/journal.pntd.0006271","article-title":"Rabies in the Americas: 1998\u20132014","volume":"12","author":"Freire de Carvalho","year":"2018","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.vaccine.2019.01.015_b0025","unstructured":"WHO. Global elimination of dog-mediated human rabies. The time is now. Report of the rabies global conference. Geneva, 10-11 December 2015. Geneva: World Health Organization; 2015. Available at: <http:\/\/apps.who.int\/iris\/bitstream\/10665\/204621\/1\/WHO_HTM_NTD_NZD_2016.02_eng.pdf?ua=1>."},{"issue":"5","key":"10.1016\/j.vaccine.2019.01.015_b0030","doi-asserted-by":"crossref","first-page":"e0006387","DOI":"10.1371\/journal.pntd.0006387","article-title":"A research agenda to reinforce rabies control: A qualitative and quantitative prioritization","volume":"12","author":"Neevel","year":"2018","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.vaccine.2019.01.015_b0035","unstructured":"WHO. Expert consultation on rabies. Third report. Technical Report Series 1012, 2018. Geneva, Switzerland."},{"issue":"1","key":"10.1016\/j.vaccine.2019.01.015_b0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/QCO.0000000000000420","article-title":"Rabies: changing prophylaxis and new insights in pathophysiology","volume":"31","author":"Ugolini","year":"2018","journal-title":"Curr Opin Infect Dis"},{"issue":"33","key":"10.1016\/j.vaccine.2019.01.015_b0045","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1016\/j.vaccine.2017.12.051","article-title":"The path towards effective antivirals against rabies","volume":"37","author":"Jochmans","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.015_b0050","doi-asserted-by":"crossref","DOI":"10.1007\/s00705-018-3814-x","article-title":"Taxonomy of the order mononegavirales: update 2018","author":"Amarasinghe","year":"2018","journal-title":"Arch Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2019.01.015_b0055","doi-asserted-by":"crossref","DOI":"10.3390\/v10030130","article-title":"Utilisation of chimeric lyssaviruses to assess vaccine protection against highly divergent lyssaviruses","volume":"10","author":"Evans","year":"2018","journal-title":"Viruses"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2019.01.015_b0060","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.vetmic.2014.07.029","article-title":"Australian bat lyssavirus infection in two horses","volume":"173","author":"Shinwari","year":"2014","journal-title":"Vet Microbiol."},{"issue":"2","key":"10.1016\/j.vaccine.2019.01.015_b0065","first-page":"146","article-title":"Possible transmission of irkut virus from dogs to humans","volume":"31","author":"Chen","year":"2018","journal-title":"Biomed Environ Sci"},{"issue":"12","key":"10.1016\/j.vaccine.2019.01.015_b0070","doi-asserted-by":"crossref","first-page":"e1006041","DOI":"10.1371\/journal.ppat.1006041","article-title":"Large-Scale Phylogenomic analysis reveals the complex evolutionary history of rabies virus in multiple carnivore hosts","volume":"12","author":"Troupin","year":"2016","journal-title":"PLoS Pathog."},{"issue":"9951","key":"10.1016\/j.vaccine.2019.01.015_b0075","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(13)62707-5","article-title":"Current status of rabies and prospects for elimination","volume":"384","author":"Fooks","year":"2014","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2019.01.015_b0080","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/tropicalmed2020005","article-title":"Four thousand years of concepts relating to rabies in animals and humans, its prevention and its cure","volume":"2","author":"Tarantola","year":"2017","journal-title":"Trop Med Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2019.01.015_b0085","doi-asserted-by":"crossref","first-page":"e0005010","DOI":"10.1371\/journal.pntd.0005010","article-title":"Validation of a rapid rabies diagnostic tool for field surveillance in developing countries","volume":"10","author":"L\u00e9chenne","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2019.01.015_b0090","doi-asserted-by":"crossref","first-page":"e0004776","DOI":"10.1371\/journal.pntd.0004776","article-title":"Evaluation of six commercially available rapid immunochromatographic tests for the diagnosis of rabies in brain material","volume":"10","author":"Eggerbauer","year":"2016","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.vaccine.2019.01.015_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2018.02.019","article-title":"Evaluation of monoclonal antibody-based direct, rapid immunohistochemical test for rabies diagnosis","author":"Feng","year":"2018","journal-title":"J Virol Methods"},{"issue":"5","key":"10.1016\/j.vaccine.2019.01.015_b0100","doi-asserted-by":"crossref","first-page":"e0197074","DOI":"10.1371\/journal.pone.0197074","article-title":"Multi-site evaluation of the LN34 pan-lyssavirus real-time RT-PCR assay for post-mortem rabies diagnostics","volume":"13","author":"Gigante","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.01.015_b0105","doi-asserted-by":"crossref","first-page":"184","DOI":"10.12688\/f1000research.10416.1","article-title":"Lyssaviruses and rabies: current conundrums, concerns, contradictions and controversies","author":"Rupprecht","year":"2017","journal-title":"F1000Res."},{"issue":"1","key":"10.1016\/j.vaccine.2019.01.015_b0110","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/tbed.12637","article-title":"Towards canine rabies elimination: economic comparisons of three project sites","volume":"65","author":"Elser","year":"2018","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2019.01.015_b0115","unstructured":"World Health Organization. Rabies vaccines: WHO position paper, April 2018 - Recommendations. Vaccine. 2018 Aug 11. pii: S0264-410X(18)30902-2."},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2019.01.015_b0120","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijpharm.2018.02.031","article-title":"Transdermal delivery of vitamin K using dissolving microneedles for the prevention of vitamin K deficiency bleeding","volume":"541","author":"Hutton","year":"2018","journal-title":"Int J Pharm."},{"key":"10.1016\/j.vaccine.2019.01.015_b0125","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jix038","article-title":"Intradermal Administration of Fractional Doses of Inactivated Poliovirus Vaccine: A Dose-Sparing Option for Polio Immunization","author":"Okayasu","year":"2017","journal-title":"J Infect Dis."},{"key":"10.1016\/j.vaccine.2019.01.015_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cct.2014.11.014","article-title":"Immunogenicity and safety of measles-mumps-rubella vaccine delivered by disposable-syringe jet injector in healthy Brazilian infants: a randomized non-inferiority study","volume":"41","author":"de Menezes","year":"2015","journal-title":"Contemp Clin Trials"},{"issue":"37","key":"10.1016\/j.vaccine.2019.01.015_b0135","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1016\/j.vaccine.2015.03.062","article-title":"Opportunities and challenges in delivering influenza vaccine by microneedle patch","volume":"33","author":"Jacoby","year":"2015","journal-title":"Vaccine."},{"issue":"4","key":"10.1016\/j.vaccine.2019.01.015_b0140","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1080\/21645515.2016.1255834","article-title":"Injecting rabies immunoglobulin (RIG) into wounds only: a significant saving of lives and costly RIG","volume":"13","author":"Bharti","year":"2017","journal-title":"Hum Vaccin Immunother."},{"issue":"10","key":"10.1016\/j.vaccine.2019.01.015_b0145","first-page":"79","article-title":"Safety and neutralizing rabies antibody in healthy subjects given a single dose of rabies immune globulin caprylate\/chromatography purified","volume":"26","author":"Hanna","year":"2018","journal-title":"Clin Pharmacol."},{"issue":"3","key":"10.1016\/j.vaccine.2019.01.015_b0150","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/cid\/cix791","article-title":"Comparison of a novel human rabies monoclonal antibody to human rabies immunoglobulin for postexposure prophylaxis: a phase 2\/3, randomized, single-blind, noninferiority, controlled study","volume":"66","author":"Gogtay","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2019.01.015_b0155","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2460\/javma.248.5.505","article-title":"Compendium of Animal Rabies Prevention and Control, 2016","volume":"248","author":"Brown","year":"2016","journal-title":"J Am Vet Med Assoc."},{"issue":"46","key":"10.1016\/j.vaccine.2019.01.015_b0160","doi-asserted-by":"crossref","first-page":"5504","DOI":"10.1016\/j.vaccine.2016.10.015","article-title":"Thermotolerance of an inactivated rabies vaccine for dogs","volume":"34","author":"Lankester","year":"2016","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2019.01.015_b0165","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4149\/av_2017_301","article-title":"Viral vaccine stabilizers: status and trends","volume":"61","author":"Cardoso","year":"2017","journal-title":"Acta Virol"},{"issue":"15","key":"10.1016\/j.vaccine.2019.01.015_b0170","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1186\/s12879-015-1320-2","article-title":"Vaccinate-assess-move method of mass canine rabies vaccination utilizing mobile technology data collection in Ranchi, India","volume":"29","author":"Gibson","year":"2015","journal-title":"BMC Infect Dis."},{"issue":"7","key":"10.1016\/j.vaccine.2019.01.015_b0175","doi-asserted-by":"crossref","first-page":"e0200942","DOI":"10.1371\/journal.pone.0200942","article-title":"One million dog vaccinations recorded on mHealth innovation used to direct teams in numerous rabies control campaigns","volume":"13","author":"Gibson","year":"2018","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.vaccine.2019.01.015_b0180","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.4269\/ajtmh.16-0785","article-title":"Cost-effectiveness evaluation of a novel integrated bite case management program for the control of human rabies, Haiti 2014\u20132015","volume":"96","author":"Undurraga","year":"2017","journal-title":"Am J Trop Med Hyg."},{"issue":"12","key":"10.1016\/j.vaccine.2019.01.015_b0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003310","article-title":"Knowledge, attitudes and practices (KAP) about rabies prevention and control: a community survey in Tanzania","volume":"8","author":"Sambo","year":"2014","journal-title":"PLoS Negl Trop Dis."},{"issue":"12","key":"10.1016\/j.vaccine.2019.01.015_b0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144830","article-title":"da Silva ES, Barbosa DS, Struchiner CJ. Population estimation methods for free-ranging dogs: A systematic review","volume":"10","author":"Belo","year":"2015","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.vaccine.2019.01.015_b0195","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.vaccine.2015.11.033","article-title":"Operational performance and analysis of two rabies vaccination campaigns in N'Djamena Chad","volume":"34","author":"L\u00e9chenne","year":"2016","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2019.01.015_b0200","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3389\/fvets.2017.00109","article-title":"The role of dog population management in rabies elimination\u2014a review of current approaches and future opportunities","volume":"10","author":"Taylor","year":"2017","journal-title":"Front Vet Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2019.01.015_b0205","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13567-018-0554-6","article-title":"Oral vaccination of dogs: a well-studied and undervalued tool for achieving human and dog rabies elimination","volume":"49","author":"Cliquet","year":"2018","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2019.01.015_b0210","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/tropicalmed2020017","article-title":"Field Studies Evaluating Bait Acceptance and Handling by Dogs in Navajo Nation","volume":"2","author":"Bender","year":"2017","journal-title":"USA. Trop Med Infect Dis"},{"key":"10.1016\/j.vaccine.2019.01.015_b0215","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.antiviral.2015.06.011","article-title":"Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination","volume":"121","author":"Shuai","year":"2015","journal-title":"Antiviral Res"},{"issue":"6","key":"10.1016\/j.vaccine.2019.01.015_b0220","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.vaccine.2017.12.076","article-title":"An assessment of shedding with the oral rabies virus vaccine strain SPBN GASGAS in target and non-target species","volume":"36","author":"Vos","year":"2018","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2019.01.015_b0225","doi-asserted-by":"crossref","first-page":"220","DOI":"10.7774\/cevr.2014.3.2.220","article-title":"First trials of oral vaccination with rabies SAG2 dog baits in Morocco","volume":"3","author":"Darkaoui","year":"2014","journal-title":"Clin Exp Vaccine Res."},{"issue":"11","key":"10.1016\/j.vaccine.2019.01.015_b0230","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1007\/s00705-017-3499-6","article-title":"Protective immune response of oral rabies vaccine in stray dogs, corsacs and steppe wolves after a single immunization","volume":"162","author":"Zhugunissov","year":"2017","journal-title":"Arch Virol."},{"issue":"33","key":"10.1016\/j.vaccine.2019.01.015_b0235","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1016\/j.vaccine.2017.09.096","article-title":"Evaluation of immune responses in dogs to oral rabies vaccine under field conditions","volume":"37","author":"Smith","year":"2019","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2019.01.015_b0240","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13567-017-0459-9","article-title":"Oral vaccination of wildlife using a vaccinia-rabies-glycoprotein recombinant virus vaccine (RABORAL V-RG(\u00ae)): a global review","volume":"48","author":"Maki","year":"2017","journal-title":"Vet Res"},{"issue":"2","key":"10.1016\/j.vaccine.2019.01.015_b0245","first-page":"47","article-title":"Field studies evaluating bait acceptance and handling by free-roaming dogs in Thailand","volume":"5","author":"Kasemsuwan","year":"2018","journal-title":"Vet Sci"},{"issue":"8","key":"10.1016\/j.vaccine.2019.01.015_b0250","doi-asserted-by":"crossref","first-page":"e828","DOI":"10.1016\/S2214-109X(18)30302-4","article-title":"New global strategic plan to eliminate dog-mediated rabies by 2030","volume":"6","author":"Minghui","year":"2018","journal-title":"Lancet Glob Health"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19300684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19300684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:34:53Z","timestamp":1759401293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19300684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":50,"alternative-id":["S0264410X19300684"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.01.015","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Priorities in applied research to ensure programmatic success in the global elimination of canine rabies","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}